Fabry disease (FD) is a rare X-linked lysosomal storage disease based on a deficiency of α-
galactosidase A (AGAL) caused by mutations in the α-galactosidase A gene (GLA). The …

Fabry disease (FD) is a lysosomal storage disorder characterised by a deficiency in the
enzyme α-galactosidase A resulting in sphingolipid deposition which causes progressive …

Fabry's disease is an X‑linked lysosomal storage disorder caused by a deficiency of alpha‑
galactosidase A enzyme with the progressive accumulation of globotriaosylceramide in …

Anderson-Fabry disease is an X-linked lysosomal storage disorder caused by a defect in the
α-galactosidase A gene, which leads to the deficiency of the hydrolytic enzyme α …

Fabry disease is an X-linked inherited condition due to the absence or reduction of α-
galactosidase activity in lysosomes, that results in accumulation of globotriaosylceramide …

Fabry disease (FD) is an X-linked inborn error of glycosphingolipid metabolism due to the
deficiency of α-galactosidase A. The progressive accumulation of globotriaosylceramide …

Fabry disease is a rare, X‐linked lysosomal storage disease caused by an inborn deficiency
of α‐galactosidase A, which results in progressive accumulation of globotriaosylceramide in …

Fabry disease is an X-linked inherited lysosomal disorder due to dysfunctions of the
lysosomal enzyme alpha-galactosidase A, causing insufficient breakdown of glycolipids …

Neurological manifestations of Fabry disease occur in both the peripheral nervous system
(PNS) and central nervous system (CNS), with globotriaosylceramide (Gb3) accumulation in …

Characteristic clinical manifestations of AFD such as acroparesthesias, angiokeratoma,
corneal opacity, hypo/and anhidrosis, gastrointestinal symptoms, renal and cardiac …